Literature DB >> 18790734

Hereditary cancer-associated missense mutations in hMSH6 uncouple ATP hydrolysis from DNA mismatch binding.

Jennifer L Cyr1, Christopher D Heinen.   

Abstract

Hereditary nonpolyposis colorectal cancer is caused by germline mutations in DNA mismatch repair genes. The majority of cases are associated with mutations in hMSH2 or hMLH1; however, about 12% of cases are associated with alterations in hMSH6. The hMSH6 protein forms a heterodimer with hMSH2 that is capable of recognizing a DNA mismatch. The heterodimer then utilizes its adenosine nucleotide processing ability in an, as of yet, unclear mechanism to facilitate communication between the mismatch and a distant strand discrimination site. The majority of reported mutations in hMSH6 are deletions or truncations that entirely eliminate the function of the protein; however, nearly a third of the reported variations are missense mutations whose functional significance is unclear. We analyzed seven cancer-associated single amino acid alterations in hMSH6 distributed throughout the functional domains of the protein to determine their effect on the biochemical activity of the hMSH2-hMSH6 heterodimer. Five alterations affect mismatch-stimulated ATP hydrolysis activity providing functional evidence that missense variants of hMSH6 can disrupt mismatch repair function and may contribute to disease. Of the five mutants that affect mismatch-stimulated ATP hydrolysis, only two (R976H and H1248D) affect mismatch recognition. Thus, three of the mutants (G566R, V878A, and D803G) appear to uncouple the mismatch binding and ATP hydrolysis activities of the heterodimer. We also demonstrate that these three mutations alter ATP-dependent conformation changes of hMSH2-hMSH6, suggesting that cancer-associated mutations in hMSH6 can disrupt the intramolecular signaling that coordinates mismatch binding with adenosine nucleotide processing.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18790734      PMCID: PMC2581557          DOI: 10.1074/jbc.M806018200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

1.  Composite active site of an ABC ATPase: MutS uses ATP to verify mismatch recognition and authorize DNA repair.

Authors:  M S Junop; G Obmolova; K Rausch; P Hsieh; W Yang
Journal:  Mol Cell       Date:  2001-01       Impact factor: 17.970

Review 2.  The multifaceted mismatch-repair system.

Authors:  Josef Jiricny
Journal:  Nat Rev Mol Cell Biol       Date:  2006-05       Impact factor: 94.444

Review 3.  Mutations at coding repeat sequences in mismatch repair-deficient human cancers: toward a new concept of target genes for instability.

Authors:  Alex Duval; Richard Hamelin
Journal:  Cancer Res       Date:  2002-05-01       Impact factor: 12.701

Review 4.  An update of HNPCC (Lynch syndrome).

Authors:  H T Lynch; T Smyrk; J Lynch
Journal:  Cancer Genet Cytogenet       Date:  1997-01

5.  Biochemical basis for dominant mutations in the Saccharomyces cerevisiae MSH6 gene.

Authors:  Martin T Hess; Marc L Mendillo; Dan J Mazur; Richard D Kolodner
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-05       Impact factor: 11.205

6.  Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.

Authors:  Jesper V Olsen; Blagoy Blagoev; Florian Gnad; Boris Macek; Chanchal Kumar; Peter Mortensen; Matthias Mann
Journal:  Cell       Date:  2006-11-03       Impact factor: 41.582

7.  HNPCC mutations in hMSH2 result in reduced hMSH2-hMSH6 molecular switch functions.

Authors:  Christopher D Heinen; Teresa Wilson; Anthony Mazurek; Mark Berardini; Charles Butz; Richard Fishel
Journal:  Cancer Cell       Date:  2002-06       Impact factor: 31.743

Review 8.  Functional analysis helps to clarify the clinical importance of unclassified variants in DNA mismatch repair genes.

Authors:  Jianghua Ou; Renée C Niessen; Anne Lützen; Rolf H Sijmons; Jan H Kleibeuker; Niels de Wind; Lene Juel Rasmussen; Robert M W Hofstra
Journal:  Hum Mutat       Date:  2007-11       Impact factor: 4.878

9.  Structure of the human MutSalpha DNA lesion recognition complex.

Authors:  Joshua J Warren; Timothy J Pohlhaus; Anita Changela; Ravi R Iyer; Paul L Modrich; Lorena S Beese
Journal:  Mol Cell       Date:  2007-05-25       Impact factor: 17.970

10.  Biallelic germline mutations of mismatch-repair genes: a possible cause for multiple pediatric malignancies.

Authors:  Jan-Werner Poley; Anja Wagner; Monique M C P Hoogmans; Fred H Menko; Carli Tops; Johan M Kros; Roel E Reddingius; Hanne Meijers-Heijboer; Ernst J Kuipers; Winand N M Dinjens
Journal:  Cancer       Date:  2007-06-01       Impact factor: 6.860

View more
  13 in total

1.  Human MSH2 (hMSH2) protein controls ATP processing by hMSH2-hMSH6.

Authors:  Christopher D Heinen; Jennifer L Cyr; Christopher Cook; Nidhi Punja; Miho Sakato; Robert A Forties; Juana Martin Lopez; Manju M Hingorani; Richard Fishel
Journal:  J Biol Chem       Date:  2011-09-19       Impact factor: 5.157

2.  The predicted truncation from a cancer-associated variant of the MSH2 initiation codon alters activity of the MSH2-MSH6 mismatch repair complex.

Authors:  Jennifer L Cyr; Graham D Brown; Jennifer Stroop; Christopher D Heinen
Journal:  Mol Carcinog       Date:  2011-08-11       Impact factor: 4.784

3.  Functional analysis of rare variants in mismatch repair proteins augments results from computation-based predictive methods.

Authors:  Sanjeevani Arora; Peter J Huwe; Rahmat Sikder; Manali Shah; Amanda J Browne; Randy Lesh; Emmanuelle Nicolas; Sanat Deshpande; Michael J Hall; Roland L Dunbrack; Erica A Golemis
Journal:  Cancer Biol Ther       Date:  2017-05-11       Impact factor: 4.742

4.  Sub-cellular localization analysis of MSH6 missense mutations does not reveal an overt MSH6 nuclear transport impairment.

Authors:  Laura Belvederesi; Francesca Bianchi; Cristian Loretelli; Raffaella Bracci; Stefano Cascinu; Riccardo Cellerino
Journal:  Fam Cancer       Date:  2012-12       Impact factor: 2.375

Review 5.  Genotype to phenotype: analyzing the effects of inherited mutations in colorectal cancer families.

Authors:  Christopher D Heinen
Journal:  Mutat Res       Date:  2009-09-17       Impact factor: 2.433

6.  Mismatch repair analysis of inherited MSH2 and/or MSH6 variation pairs found in cancer patients.

Authors:  Jukka Kantelinen; Minttu Kansikas; Satu Candelin; Heather Hampel; Betsy Smith; Liisa Holm; Reetta Kariola; Minna Nyström
Journal:  Hum Mutat       Date:  2012-06-11       Impact factor: 4.878

7.  Determining the functional significance of mismatch repair gene missense variants using biochemical and cellular assays.

Authors:  Christopher D Heinen; Lene Juel Rasmussen
Journal:  Hered Cancer Clin Pract       Date:  2012-07-23       Impact factor: 2.857

8.  CoDP: predicting the impact of unclassified genetic variants in MSH6 by the combination of different properties of the protein.

Authors:  Hiroko Terui; Kiwamu Akagi; Hiroshi Kawame; Kei Yura
Journal:  J Biomed Sci       Date:  2013-04-28       Impact factor: 8.410

9.  Verification of the three-step model in assessing the pathogenicity of mismatch repair gene variants.

Authors:  Minttu Kansikas; Reetta Kariola; Minna Nyström
Journal:  Hum Mutat       Date:  2011-01       Impact factor: 4.878

10.  Folding of Toll-like receptors by the HSP90 paralogue gp96 requires a substrate-specific cochaperone.

Authors:  Bei Liu; Yi Yang; Zhijuan Qiu; Matthew Staron; Feng Hong; Yi Li; Shuang Wu; Yunfeng Li; Bing Hao; Robert Bona; David Han; Zihai Li
Journal:  Nat Commun       Date:  2010-09-21       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.